Drug intelligence / Profile preview

Oliceft

Development stage
Unknown
Lead developer
Makshi Healthcare
Modality
Small Molecules
01

Overview

Oliceft is a brand of antibiotic products marketed by Makshi Healthcare, primarily featuring the third-generation cephalosporin **ceftriaxone**. The product line includes Oliceft-1000, which contains ceftriaxone sodium, and Oliceft-S, a fixed-dose combination of ceftriaxone and the beta-lactamase inhibitor **sulbactam**. Ceftriaxone exerts its bactericidal effect by binding to and inhibiting penicillin-binding proteins (PBPs) involved in bacterial cell wall synthesis, which leads to cell lysis and death. The addition of sulbactam in the Oliceft-S formulation protects ceftriaxone from degradation by certain beta-lactamase enzymes, thereby extending its spectrum of activity against resistant bacterial strains. These medications are indicated for the treatment of various serious systemic infections, including lower respiratory tract infections, urinary tract infections, meningitis, and sepsis.

Brand names
Oliceft-1000Oliceft1000Oliceft 1000Oliceft-SOliceft-250Oliceft250Oliceft 250Oliceft-500Oliceft500Oliceft 500Oliceft-Makshi
Other names
Ceftriaxone Makshi
02

Targets

PBP (Penicillin-binding protein family)β-lactamase

Beyond the preview

Go deeper on Oliceft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oliceft.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call